BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease
Saideh Fakharzadeh,1,2 Hassan Argani,1 Simin Dadashzadeh,3 Somayeh Kalanaky,2 Peyman Mohammadi Torbati,4 Mohammad Hassan Nazaran,2 Abbas Basiri5 1Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Department of Research and Development, Sodour Ahra...
Guardado en:
Autores principales: | Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ca95d4cb0cc4c39978d2b738cb55c0c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DIBc, a nanochelating-based nano metal-organic framework, shows anti-diabetic effects in high-fat diet and streptozotocin-induced diabetic rats
por: Fakharzadeh S, et al.
Publicado: (2019) -
GFc7 as a Smart Growth Nanofactor for ex vivo Expansion and Cryoprotection of Humans’ Hematopoietic Stem Cells
por: Hafizi M, et al.
Publicado: (2020) -
Metastatic and locally aggressive BCC: Current treatment options
por: Máire‐Caitlín Casey, et al.
Publicado: (2021) -
Chronic Kidney Disease Related Anemia- A Narrative Review
por: Martina Hrvačić, et al.
Publicado: (2021) -
Renal Expression of AQP1 in the High-fat Nutritional Obesity of Rat
por: Wang,Jinbao, et al.
Publicado: (2019)